Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medco Builds Outcomes Research Capabilities With REMS Expert United BioSource

This article was originally published in The Pink Sheet Daily

Executive Summary

Medco is adding a new business capability - drug outcomes research for biopharmaceutical companies - with the planned acquisition of information services company United BioSource.

You may also be interested in...



Express Scripts Realignment Identifies Non-Core Businesses

Express Scripts is “looking at strategic alternatives” for some of its non-core businesses, which include international ventures, UBC and PolyMedica.

Aetna Internal PBM No Longer In Play With CVS Caremark Contract

Aetna's new 12-year contract to merge some of its internal pharmacy benefit management operations with CVS Caremark appears to take Aetna's in-house PBM out of play as a potential acquisition target

Express Scripts Purchase Deal For NextRx Includes 10-Year PBM Contract With WellPoint

With the acquisition of the largest plan-owned pharmacy benefit manager, Express Scripts will move to second place among the big stand-alone PBMs, ahead of CVS Caremark.

Related Content

Topics

UsernamePublicRestriction

Register

PS071042

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel